Physician profile
Jonathan T Jan
NPI 1952661118
$6,958.96
in general payments reported to CMS, 2019-2025
23 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,214 · 2020: $300 · 2021: $489 · 2022: $842 · 2023: $1,141 · 2024: $2,561 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,755 · Travel and Lodging: $1,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,755.05 |
| Travel and Lodging | $1,359.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $2,151.66 | 2022-2024 | Envista Aspire Iol, Stellaris Elite, Teneo |
| Alcon Vision LLC | $1,393.79 | 2019-2025 | Clareon, Tryptyr, Rocklatan |
| Abbvie INC. | $581.25 | 2022-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $388.49 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $369.04 | 2019-2024 | Cequa |
| Oyster Point Pharma, INC. | $326.75 | 2022-2025 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $280.95 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $260.42 | 2019-2023 | Tecnis Iol |
| Allergan, INC. | $180.00 | 2019-2022 | |
| Biotissue Holdings INC. | $175.62 | 2019-2025 | |
| Carl Zeiss Meditec, INC. | $137.19 | 2023 | Artevo 800, Lumera 700 |
| Rxsight INC | $131.57 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Dompe US, INC. | $130.84 | 2020-2025 | Oxervate |
| Optos, INC. | $65.62 | 2020 | |
| Kala Pharmaceuticals, INC. | $59.47 | 2019-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $56.42 | 2019-2022 | |
| Glaukos Corporation | $53.11 | 2024-2025 | Idosetr, Istent Trabecular Micro-Bypass System Model Is3 |
| Sight Sciences, INC. | $52.32 | 2019-2022 | |
| Rayner Intraocular Lenses Limited | $50.89 | 2022-2023 | Rayone Emv, Omidria, Rayone Aspheric |
| Ocular Therapeutix, INC. | $34.35 | 2023-2025 | Dextenza |
| Lensar, INC. | $34.20 | 2024 | Lensar Laser System |
| Eyevance Pharmaceuticals LLC | $27.18 | 2019-2022 | |
| Thea Pharma INC. | $17.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Jan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.